List of Excipients in API niacin and lovastatin
✉ Email this page to a colleague
Excipients in NDA-approved (novel) drugs containing niacin and lovastatin
| Company | Tradename | Ingredient | NDC | Excipient | Potential Generic Entry |
|---|---|---|---|---|---|
| Physicians Total Care Inc | ADVICOR | niacin and lovastatin | 54868-4807 | FERRIC OXIDE RED | |
| Physicians Total Care Inc | ADVICOR | niacin and lovastatin | 54868-4807 | FERRIC OXIDE YELLOW | |
| Physicians Total Care Inc | ADVICOR | niacin and lovastatin | 54868-4807 | HYPROMELLOSES | |
| Physicians Total Care Inc | ADVICOR | niacin and lovastatin | 54868-4807 | POLYETHYLENE GLYCOLS | |
| Physicians Total Care Inc | ADVICOR | niacin and lovastatin | 54868-4807 | POLYSORBATE 80 | |
| Physicians Total Care Inc | ADVICOR | niacin and lovastatin | 54868-4807 | POVIDONE | |
| >Company | >Tradename | >Ingredient | >NDC | >Excipient | >Potential Generic Entry |
Detailed excipient profiles for niacin and lovastatin
Excipient focus: FERRIC OXIDE RED
niacin and lovastatin drug variants containing FERRIC OXIDE RED
| Company | Ingredient | NDC |
|---|---|---|
| Physicians Total Care Inc | niacin and lovastatin | 54868-4807 |
| >Company | >Ingredient | >NDC |
niacin and lovastatin drug variants not containing FERRIC OXIDE RED
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: FERRIC OXIDE YELLOW
niacin and lovastatin drug variants containing FERRIC OXIDE YELLOW
| Company | Ingredient | NDC |
|---|---|---|
| Physicians Total Care Inc | niacin and lovastatin | 54868-4807 |
| >Company | >Ingredient | >NDC |
niacin and lovastatin drug variants not containing FERRIC OXIDE YELLOW
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: HYPROMELLOSES
niacin and lovastatin drug variants containing HYPROMELLOSES
| Company | Ingredient | NDC |
|---|---|---|
| Physicians Total Care Inc | niacin and lovastatin | 54868-4807 |
| >Company | >Ingredient | >NDC |
niacin and lovastatin drug variants not containing HYPROMELLOSES
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: POLYETHYLENE GLYCOLS
niacin and lovastatin drug variants containing POLYETHYLENE GLYCOLS
| Company | Ingredient | NDC |
|---|---|---|
| Physicians Total Care Inc | niacin and lovastatin | 54868-4807 |
| >Company | >Ingredient | >NDC |
niacin and lovastatin drug variants not containing POLYETHYLENE GLYCOLS
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: POLYSORBATE 80
niacin and lovastatin drug variants containing POLYSORBATE 80
| Company | Ingredient | NDC |
|---|---|---|
| Physicians Total Care Inc | niacin and lovastatin | 54868-4807 |
| >Company | >Ingredient | >NDC |
niacin and lovastatin drug variants not containing POLYSORBATE 80
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: POVIDONE
niacin and lovastatin drug variants containing POVIDONE
| Company | Ingredient | NDC |
|---|---|---|
| Physicians Total Care Inc | niacin and lovastatin | 54868-4807 |
| >Company | >Ingredient | >NDC |
niacin and lovastatin drug variants not containing POVIDONE
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: STEARIC ACID
niacin and lovastatin drug variants containing STEARIC ACID
| Company | Ingredient | NDC |
|---|---|---|
| Physicians Total Care Inc | niacin and lovastatin | 54868-4807 |
| >Company | >Ingredient | >NDC |
niacin and lovastatin drug variants not containing STEARIC ACID
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: TITANIUM DIOXIDE
niacin and lovastatin drug variants containing TITANIUM DIOXIDE
| Company | Ingredient | NDC |
|---|---|---|
| Physicians Total Care Inc | niacin and lovastatin | 54868-4807 |
| >Company | >Ingredient | >NDC |
niacin and lovastatin drug variants not containing TITANIUM DIOXIDE
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Make Better Decisions: Try a trial or see plans & pricing
Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.
ISSN: 2162-2639
Privacy and Cookies
Terms & Conditions
Site Map
DrugPatentWatch Alternatives
LOE / Generic Entry Opportunies 2025 - 2026
NCE-1 Patent Challenge Dates 2025 - 2026
Friedman, Yali. "DrugPatentWatch" DrugPatentWatch, thinkBiotech, 2025, www.DrugPatentWatch.com.
See Primary Research Papers Citing DrugPatentWatch